|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 38/57 | (2013.01) | ||
| C07K 14/81 | (2006.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 31/16 | (2006.01) | ||
| C07K 14/8121 | (2013.01) | ||
| C07K 14/44 | (2006.01) | ||
| C07K 14/44 | (2013.01) |
| (11) | Patento numeris | 4135756 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21718158.5 |
| Europos patento paraiškos padavimo data | 2021-04-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2021/060098 |
| Data | 2021-04-19 |
| (87) | Numeris | WO 2021/209644 |
| Data | 2021-10-21 |
| (30) | Numeris | Data | Šalis |
| 20170253 | 2020-04-17 | EP | |
| 202063011738 P | 2020-04-17 | US |
| (72) |
GIANNETTI, Bruno , NL
RELAN, Anurag , NL
SCHAALE-MAASS, Juergen Ulrich , NL
|
| (73) |
Pharming Intellectual Property B.V. ,
Darwinweg 24, 2333 CR Leiden,
NL
|
| (54) | C1 ESTERASE INHIBITOR TO TREAT CORONAVIRAL INFECTION-RELATED RESPIRATORY DISTRESS |
| C1 ESTERASE INHIBITOR TO TREAT CORONAVIRAL INFECTION-RELATED RESPIRATORY DISTRESS |